EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitMetaanalyseOpen Access

Impact of β-blocker therapy after acute myocardial infarction in patients with preserved ejection fraction: a meta-analysis

Tony Chandy Babu, Hala Sharaf, Haniya Mallick, Omar Alzaabi, Moaz Alowami, Abdul Khan, Eman Ibrahim Elzain Hassan, Rajdeepsinh Hariharsinh Rana, Yasmeen Maarraoui, Mohammed Alrubaei, Zenab Ehsan, Eeshal Zulfiqar

Archives of Medical Science – Atherosclerotic Diseases · 14.05.2026 · 11 (1) · 78-86

DOI: 10.5114/amsad/220339 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 14.05.2026. Verfasst von Tony Chandy Babu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Worcestershire Acute Hospitals NHS Trust, UK. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite earlier evidence, the benefit of long-term β-blockers after myocardial infarction (MI) in patients with preserved or mildly reduced ejection fraction remains unclear in the modern reperfusion era. Material and Methods We conducted a PRISMA-guided systematic review and meta-analysis by searching the PubMed, Google Scholar, and Cochrane databases, pooling results using a random effects model with 95% CIs.

Results

Five RCTs, including a total of 23,524 participants, were analysed. β-blocker therapy showed no significant effect on all-cause mortality (RR = 0.98, 95% CI: 0.87–1.11) or cardiovascular mortality (RR = 1.06, 95% CI: 0.83–1.36). Similarly, no significant differences were observed for secondary outcomes: major adverse cardiovascular events (MACE) (RR = 0.96, 95% CI: 0.85–1.07), recurrent MI (RR = 0.89, 95% CI: 0.78–1.02), stroke (RR = 1.27, 95% CI: 0.92–1.76), or hospitalisations for HF (HF) (RR = 0.77, 95% CI: 0.56–1.05).

Conclusions

Long-term β-blockers showed no reduction in mortality, recurrent MI, stroke, MACE, or HF admissions, indicating limited routine benefit.

Schlagwörter

Stichwörter der Autor:innen

mortalitymyocardial infarctionpreserved ejection fractionβ-blockers

Autor:innen und Institutionen

  • Worcestershire Acute Hospitals NHS Trust, UK.
  • Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates University (UAEU), UAE.
  • Nixor College, Karachi, Pakistan.
  • United Arab Emirates University, Abu Dhabi, UAE.
  • St. Joseph's Healthcare Hamilton Charlton Campus, Hamilton, Ontario, Canada.
  • Department of Cardiology, University Hospitals Plymouth NHS Trust, UK.

Zitieren

APA

Babu, T. C., Sharaf, H., Mallick, H., Alzaabi, O., Alowami, M., Khan, A., Hassan, E. I. E., Rana, R. H., Maarraoui, Y., Alrubaei, M., Ehsan, Z., & Zulfiqar, E. (2026). Impact of β-blocker therapy after acute myocardial infarction in patients with preserved ejection fraction: a meta-analysis. Archives of Medical Science – Atherosclerotic Diseases, 11(1), 78-86. https://doi.org/10.5114/amsad/220339

Vancouver

Babu TC, Sharaf H, Mallick H, Alzaabi O, Alowami M, Khan A, et al. Impact of β-blocker therapy after acute myocardial infarction in patients with preserved ejection fraction: a meta-analysis. Archives of Medical Science – Atherosclerotic Diseases. 2026;11(1):78-86. doi:10.5114/amsad/220339

BibTeX
@article{Babu2026,
  author = {Babu, Tony Chandy and Sharaf, Hala and Mallick, Haniya and Alzaabi, Omar and Alowami, Moaz and Khan, Abdul and Hassan, Eman Ibrahim Elzain and Rana, Rajdeepsinh Hariharsinh and Maarraoui, Yasmeen and Alrubaei, Mohammed and Ehsan, Zenab and Zulfiqar, Eeshal},
  title = {Impact of β-blocker therapy after acute myocardial infarction in patients with preserved ejection fraction: a meta-analysis},
  journal = {Archives of Medical Science – Atherosclerotic Diseases},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {78--86},
  doi = {10.5114/amsad/220339}
}
Kostenlos starten →